全文获取类型
收费全文 | 75016篇 |
免费 | 5702篇 |
国内免费 | 1796篇 |
专业分类
耳鼻咽喉 | 786篇 |
儿科学 | 1527篇 |
妇产科学 | 1549篇 |
基础医学 | 8512篇 |
口腔科学 | 1730篇 |
临床医学 | 7857篇 |
内科学 | 15809篇 |
皮肤病学 | 1498篇 |
神经病学 | 5025篇 |
特种医学 | 1707篇 |
外国民族医学 | 6篇 |
外科学 | 9388篇 |
综合类 | 6297篇 |
现状与发展 | 2篇 |
一般理论 | 17篇 |
预防医学 | 5967篇 |
眼科学 | 1844篇 |
药学 | 6027篇 |
54篇 | |
中国医学 | 2336篇 |
肿瘤学 | 4576篇 |
出版年
2024年 | 178篇 |
2023年 | 853篇 |
2022年 | 1969篇 |
2021年 | 3335篇 |
2020年 | 2242篇 |
2019年 | 2368篇 |
2018年 | 2687篇 |
2017年 | 2174篇 |
2016年 | 1961篇 |
2015年 | 2759篇 |
2014年 | 3690篇 |
2013年 | 4367篇 |
2012年 | 6626篇 |
2011年 | 6773篇 |
2010年 | 4299篇 |
2009年 | 3751篇 |
2008年 | 4898篇 |
2007年 | 4868篇 |
2006年 | 4348篇 |
2005年 | 3926篇 |
2004年 | 3160篇 |
2003年 | 2876篇 |
2002年 | 2467篇 |
2001年 | 623篇 |
2000年 | 502篇 |
1999年 | 505篇 |
1998年 | 455篇 |
1997年 | 402篇 |
1996年 | 343篇 |
1995年 | 315篇 |
1994年 | 262篇 |
1993年 | 230篇 |
1992年 | 234篇 |
1991年 | 174篇 |
1990年 | 153篇 |
1989年 | 143篇 |
1988年 | 121篇 |
1987年 | 103篇 |
1986年 | 116篇 |
1985年 | 102篇 |
1984年 | 108篇 |
1983年 | 89篇 |
1982年 | 117篇 |
1981年 | 127篇 |
1980年 | 75篇 |
1979年 | 82篇 |
1978年 | 54篇 |
1977年 | 67篇 |
1976年 | 60篇 |
1973年 | 42篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
11.
12.
13.
14.
15.
16.
17.
Jose M. Fernández-Cebrián Peter Vorwald Kuborn Mar Pardo de Lama Alfonso Sanjuanbenito Dehesa Manuel Nevado Santos Pedro A. Pacheco Martínez Beatriz Fernández-Escudero 《Clinical & translational oncology》2005,7(3):101-109
Colorectal cancer is one of the best studied of all malignant diseases interms of genetics and/or molecular prognostic factors. These factors, and relationships with prognosis, may have important implications especially in the design of surgical and adjuvant chemo-radiotherapy options. However, the true prognostic significance of all known factors has yet to be realised. We have reviewed the literature with specific focus on the role of molecular markers involved in prognosis and the prediction of response to adjuvant treatment. 相似文献
18.
Borras Merce; Valdivielso Jose M.; Egido Ramon; Vicente de Vera Pilar; Bordalba Josep Ramon; Fernandez Elvira 《Nephrology, dialysis, transplantation》2006,21(3):789-791
19.
Fix Joseph A. Alexander Jose Cortese Margot Engle Karen Leppert Paula Repta A. J. 《Pharmaceutical research》1990,7(4):384-387
Short-chain alkyl esters of L-dopa were administered to rats and mice via oral and rectal routes. Plasma L-dopa esters and L-dopa were determined in the systemic and portal circulation by HPLC. A comparison of isopropyl, butyl, and 4-hydroxybutyl esters of L-dopa demonstrated significantly higher levels of the esters in both systemic and portal blood samples following rectal administration than following oral administration. In most cases, oral administration resulted in nondetectable (<0.01 µg/ml) levels of the esters in plasma. Correspondingly, the plasma levels of L-dopa itself were consistently higher following rectal administration. At very high oral doses (500 mg L-dopa equivalents/kg body weight), systemic plasma levels of the butyl ester could be detected (1.25 µg/ml at 10 min), which might indicate saturation of the esterase activity of the small intestine. These studies indicate that the systemic availability of L-dopa from short-chain alkyl esters of L-dopa may be best optimized by rectal administration, which avoids the relatively high esterase activity characteristic of the small intestine. 相似文献
20.
D L Lamm J I DeHaven J Shriver R Crispen D Grau M F Sarosdy 《The Journal of urology》1990,144(1):65-67
Reports of a dramatic decrease in tumor recurrence and regression of muscle invasive disease with oral bacillus Calmette-Guerin prompted us to conduct a randomized prospective comparison of oral bacillus Calmette-Guerin with the standard intravesical plus percutaneous therapy. Oral therapy consisted of 200 mg. Tice bacillus Calmette-Guerin 3 times each week. Intravesical and percutaneous Tice bacillus Calmette-Guerin at a dose of 50 mg. was given weekly for 6 weeks, at 8, 10 and 12 weeks, then at 6 months and every 6 months thereafter. Minimal side effects confirmed the safety of oral bacillus Calmette-Guerin. Tumor recurrence was documented in 21 of 33 oral bacillus Calmette-Guerin patients (64%) and 18 of 55 (33%) who received intravesical plus percutaneous therapy (p less than 0.002, chi-square test). We were unable to demonstrate any antitumor activity of oral bacillus Calmette-Guerin in this study. 相似文献